Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BJDX - Bluejay Diagnostics, Inc.


IEX Last Trade
3.76
0   0%

Share volume: 0
Last Updated: Fri 27 Dec 2024 08:18:26 PM CET
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%

$3.76
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
3.31%
1 Month
7.76%
3 Months
2,576.66%
6 Months
400.00%
1 Year
-73.29%
2 Year
17.19%
Key data
Stock price
$3.76
P/E Ratio 
0.00
DAY RANGE
$0.14 - $4.09
EPS 
$0.00
52 WEEK RANGE
$0.07 - $10.16
52 WEEK CHANGE
-$61.58
MARKET CAP 
2.400 M
YIELD 
N/A
SHARES OUTSTANDING 
12.854 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$46,128
AVERAGE 30 VOLUME 
$948,371
Company detail
CEO: Indranil Dey
Region: US
Website: bluejaydx.com
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.

Recent news